← Back to Search

Weight Discrimination Impact on Obesity Health Outcomes

N/A
Recruiting
Led By Mary A Gerend, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 minutes after delivery of the intervention
Awards & highlights

Study Summary

This trial will explore how weight discrimination affects people with obesity and their health. It will study psychological, behavioral, and physiological effects of discrimination.

Who is the study for?
Adults with obesity (BMI ≥ 30) who are at least 18 years old, can read English, have internet access for surveys, and can visit FSU's campus for a lab study. Excluded are those with major psychiatric disorders, pregnancy or nursing status, Cushing syndrome or steroid medication use, and food allergies relevant to the taste test.Check my eligibility
What is being tested?
The trial is examining how simulated weight discrimination affects people with obesity compared to a control group without discrimination. It looks at immediate cognitive, emotional, behavioral responses and cortisol levels. The study also explores if reactions vary by psychological traits or demographic factors like age and race.See study design
What are the potential side effects?
There may not be direct physical side effects from the interventions as they involve social interactions rather than medical treatments. However, participants in the weight discrimination simulation might experience negative emotions or stress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 minutes after delivery of the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 minutes after delivery of the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Affect
Change in cortisol from baseline to first follow-up assessment
Change in cortisol from baseline to second follow-up assessment
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Weight discrimination experienceExperimental Treatment1 Intervention
Participants in the experimental condition will: Learn that their group mates are biased against overweight people (i.e., they have negative attitudes toward people with higher body weight), Receive feedback about their personal attributes that is consistent with negative weight-based stereotypes (e.g., lacking self-discipline), and Not be selected as a partner for the remaining lab tasks (i.e., this experience may prompt feelings of social exclusion).
Group II: Control experienceActive Control1 Intervention
Participants in the control condition will: Learn that their group mates are very accepting of overweight people (i.e., they have positive attitudes toward people with higher body weight), Receive positive feedback about their personal attributes that is not consistent with negative weight-based stereotypes, and Will be told that one of their group members had to leave early for an emergency so the pairs cannot be assembled as usual (i.e., this experience should not prompt feelings of social exclusion).

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
199 Previous Clinical Trials
31,372 Total Patients Enrolled
16 Trials studying Obesity
1,098 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,274 Total Patients Enrolled
251 Trials studying Obesity
205,736 Patients Enrolled for Obesity
Mary A Gerend, PhDPrincipal InvestigatorFlorida State University, College of Medicine

Media Library

Control experience Clinical Trial Eligibility Overview. Trial Name: NCT05714696 — N/A
Obesity Research Study Groups: Control experience, Weight discrimination experience
Obesity Clinical Trial 2023: Control experience Highlights & Side Effects. Trial Name: NCT05714696 — N/A
Control experience 2023 Treatment Timeline for Medical Study. Trial Name: NCT05714696 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project have any current openings for volunteers?

"Affirmative. The information hosted on clinicaltrials.gov substantiates that this trial is actively recruiting participants, with 320 candidates sought from a single center. This study was first released to the public on February 1st 2023 and last updated three days later."

Answered by AI

What is the aggregate headcount of participants involved in this experiment?

"Accurately, the clinical trial registry on clinicialtrials.gov states that this medical study is actively looking for participants to join. The initial posting was published February 1st 2023 and latest changes were made on 2/3/2023. 320 individuals are intended to be enrolled from a single site."

Answered by AI
~0 spots leftby May 2024